Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lung Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1Adenocarcinoma of Lung 1

Interventions

Radiotherapy 4Cisplatin 3Cetuximab 2pembrolizumab 1monalizumab 1Tirapazamine 1Radiotherapy, Adjuvant 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Laryngectomy 1Fluorouracil 1Fibroblast Growth Factor 7 1Emulsions 1Docetaxel 1Chemoradiotherapy 1Bleomycin 1Allovectin-7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Laryngeal Diseases × Tirapazamine × Clear all
NCT00094081 2010-02-15

Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer

Sanofi

Phase 3 Completed
861 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡